View up-to-date information on Arcutis Biotherapeutics Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
IL295172A | Application | Topical roflumilast formulation having improved delivery and plasma half-life | A61K2300/00; A61K31/44; A61K47/10; A61K9/0014; A61K9/06; A61P17/00; A61P17/04 | September 01, 2022 |
AU2021214399A1 | Application | Topical roflumilast formulation having improved delivery and plasma half-life | A61K31/44; A61K47/10; A61K9/0014; A61K9/06; A61P17/00; A61P17/04 | August 25, 2022 |
WO2022169615A1 | Application | ROFLUMILAST FORMULATIONS WITH AN IMPROVED PHARMACOKINETIC PROFILE | A61K31/44; A61K47/06; A61K47/10; A61K47/14; A61K47/24; A61K9/0014; A61K9/06; A61K9/122; A61P11/00; A61P17/00 | August 11, 2022 |
EP4025214A1 | Application | VERFAHREN ZUM REDUZIEREN VON NEBENWIRKUNGEN BEI DER VERABREICHUNG VON PHOSPHODIESTERASE-4-INHIBITOREN | A61K31/44; A61K45/06; A61K47/10; A61K47/24; A61K9/0014; A61K9/06; A61K9/122; A61P11/06; A61P11/08 | July 13, 2022 |
US20220211730A1 | Application | TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE ANIONIC SURFACTANTS | A61K31/045; A61K31/122; A61K31/165; A61K31/343; A61K31/436; A61K31/513; A61K31/519; A61K31/52; A61K31/655; A61K31/662; A61K31/683; A61K35/04; A61K38/13; A61K47/06; A61K47/10; A61K47/14; A61K9/0014; A61P17/00 | July 07, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer